Products Center
Products Center
Specializing in import substitution, only high, precise and cutting-edge products
IVD Industry
Why choose Youbikang
Compare with peers
Good quality, high efficiency and low cost
Replace imports
Establish industry national standards


YouBeiKang Advantages
Youbeikang has surpassed its foreign counterparts in key indicators
After years of research and development by the team, and constantly overcome the technical difficulties, and cooperation with universities, and continue to improve the process, now batch trial production, product quality is excellent and stable, the process is mature.

Advantages
Compare with imported products, truly high quality and low price

Delivery Time
There is no doubt that the delivery time is faster than that of imported products

Quality
Strict quality control is the root of our establishment for more than ten years

Communication
No time difference, any problems at any time to communicate, timely improvement
Qualification


Shenzhen Youbeikang Technology Co., Ltd
A cross-border medical device manufacturer engaged in the production, research and development, sales and technical service of medical in vitro diagnostics (IVD) and clinical laboratory analytical instruments with spiking needles (sampling needles).

Professional Technical Team
The company has senior technical and management personnel of Japanese companies, following the management mode of Japanese companies

Advanced production equipment
In addition to the industry-leading production technology, Yubicon has invested in a series of advanced production equipment

Rational R&D direction
Specializing in import substitution, only high, precise and cutting-edge products
News
News
Follow the latest news of YoubeiKang
Song Haibo: Current situation and thinking of key raw materials for in vitro diagnosis in China
In recent years, China's IVD industry has grown rapidly at an annual growth rate of more than 15%. In 2018, China's market capacity of in vitro diagnostic products has reached 70 billion yuan, becoming the fastest growing segment of the entire medical device industry. However, according to the national per capita calculation, the annual expenditure of in vitro diagnosis per capita in China is only about US $5, far below the average level of US $25-30 in developed countries, and is still in the development stage of the industry life cycle. With the increasing attention to the health cause, the intensification of the aging process of the population, and the support of the relevant national policies for the medical industry, the construction of a healthy China continues to advance. It is expected that in the next five years or even longer, China's IVD industry will still be in a golden period of rapid development.
2023.02.14